These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 13938968)

  • 1. Persistence of maternal anti-Rh (anti-D) in an Rh-positive infant.
    NORRIS HJ; YUNIS E
    J Lancet; 1963 Jun; 83():243-4. PubMed ID: 13938968
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies of red cell fragility in anti-D hemolytic disease of the newborn.
    GREENWALT TJ; TRIANTAPHYLLOPOULOS DC
    J Lab Clin Med; 1955 Jan; 45(1):135-40. PubMed ID: 13233638
    [No Abstract]   [Full Text] [Related]  

  • 3. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of haemolytic disease of the newborn due to anti-D.
    Tovey G; Wagstaff W
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):142. PubMed ID: 6266575
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
    [No Abstract]   [Full Text] [Related]  

  • 7. [Successful emergency treatment of a case with severe hemolytic disease of the newborn due to maternal Rh deletion phenotype-D].
    Liu KL; Li BJ; Peng JY
    Zhonghua Er Ke Za Zhi; 2006 Jun; 44(6):473-4. PubMed ID: 16836866
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
    Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
    Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
    [No Abstract]   [Full Text] [Related]  

  • 9. Efforts should be made to eradicate Rh hemolytic disease of the fetus and newborn.
    Caiola G
    Obstet Gynecol Surv; 1984 Jan; 39(1):55-7. PubMed ID: 6320075
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical significance of anti-G in alloimmunized pregnant women.
    Hadley A; Poole J; Poole G
    Transfusion; 1997 Sep; 37(9):985. PubMed ID: 9308650
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of anti-G.
    Lenkiewicz B; Zupańska B
    Transfus Med; 2002 Jun; 12(3):221. PubMed ID: 12071879
    [No Abstract]   [Full Text] [Related]  

  • 12. Rh(D) haemolytic disease of the newborn: the changing scene.
    Urbaniak SJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630
    [No Abstract]   [Full Text] [Related]  

  • 13. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
    Tovey LA; Taverner JM
    Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR; Scofield TL; Moulds JJ; Swanson JL
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of Rh antibodies in pregnancy].
    ZACHARIAS K
    Dtsch Gesundheitsw; 1957 May; 12(19):581-4. PubMed ID: 13447473
    [No Abstract]   [Full Text] [Related]  

  • 16. Simple method of detecting univalent antibodies in sera containing potent bivalent Rh antibodies, with remarks concerning the pathogenesis of erythroblastosis fetalis.
    WIENER AS; HANDMAN L
    Exp Med Surg; 1948 Nov; 6(4):416-27. PubMed ID: 18104768
    [No Abstract]   [Full Text] [Related]  

  • 17. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn.
    Kumpel BM
    Clin Exp Immunol; 2008 Oct; 154(1):1-5. PubMed ID: 18727626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumption of anti-D in the erythroblastotic fetus.
    Gottvall T; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):500-3. PubMed ID: 9654170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte glycolysis in erythroblastotic newborns. Erythrocyte glycolysis also in Rh-positive red cells coated with anti-D antibodies.
    ABRAHAMOV A; DIAMOND LK
    AMA J Dis Child; 1960 Feb; 99():202-5. PubMed ID: 13791535
    [No Abstract]   [Full Text] [Related]  

  • 20. Morbus haemolyticus neonatorum in one of dizygotic twins; examinations of the duration of Rh antibody in the blood of both of them.
    KASS A
    Acta Paediatr Suppl (Upps); 1951 Dec; 40(83):81-2. PubMed ID: 14943494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.